TP53 and carcinoma: Our report not only adds new cases to this rare carcinoma arising from adenomyosis, but also provides a characteristic immunostaining profile (PTEN+, ER-, membranous β-catenin+, p53 and p16 over expression, high Ki67 index) to uncover the distinct molecular alterations in type II carcinoma.